Financial Statements — BHFAP
Balance Sheet
(in billions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 4.91 | 6.61 | 5.54 | 4.67 | 5.63 | 4.44 | 3.82 | 3.84 | 3.74 | 3.69 | 4.79 | 5.07 | 4.10 | 4.11 | 4.88 | 4.03 |
| Short-term Investments | 1.24 | -- | -- | -- | 1.81 | 1.39 | 1.35 | 1.00 | 1.13 | 1.39 | 1.13 | 0.92 | 1.06 | 1.89 | 1.29 | 1.67 |
| Total Assets | 236.80 | 244.68 | 242.65 | 234.68 | 245.16 | 237.44 | 239.69 | 223.52 | 231.55 | 230.00 | 221.64 | 228.21 | 245.05 | 254.69 | 253.86 | 241.94 |
| Long-term Debt | 3.15 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.16 | 3.44 | 3.44 | 3.44 |
| Total Liabilities | 231.18 | 238.25 | 236.91 | 229.38 | 239.57 | 233.23 | 235.43 | 219.38 | 226.57 | 224.18 | 215.76 | 217.96 | 232.17 | 238.60 | 237.68 | 226.86 |
| Retained Earnings | (1.45) | (0.82) | (1.30) | (1.39) | (1.79) | (1.97) | (2.00) | (0.59) | (1.07) | (0.89) | 0.30 | 0.98 | -0.00 | (0.70) | (1.09) | (1.12) |
| Total Stockholder Equity | 5.56 | 6.36 | 5.67 | 5.24 | 5.53 | 4.14 | 4.20 | 4.07 | 4.91 | 5.75 | 5.81 | 10.19 | 12.81 | 16.03 | 16.11 | 15.02 |
Income Statement
(in billions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Net Premiums Earned | 0.17 | 0.17 | 0.17 | 0.17 | 0.19 | 0.21 | 0.18 | 0.18 | 0.20 | 0.23 | 0.19 | 0.21 | 0.20 | 0.17 | 0.16 | 0.17 | 0.17 | 0.17 | 0.19 | 0.16 |
| Net Investment Income | 1.26 | 1.33 | 1.33 | 1.29 | 1.30 | 1.37 | 1.29 | 1.31 | 1.25 | 1.21 | 1.20 | 1.20 | 1.06 | 1.05 | 0.88 | 1.06 | 1.15 | 1.20 | 1.28 | 1.21 |
| Total Revenue | 1.53 | 1.69 | 1.82 | 0.87 | 2.39 | 1.21 | 2.02 | 1.43 | 0.07 | 1.40 | 1.17 | 0.26 | 1.28 | 0.45 | 1.48 | 3.80 | 2.74 | 2.02 | 2.51 | 1.68 |
| Benefits & Claims | 0.64 | 0.70 | (0.25) | 0.71 | 0.65 | 0.66 | 0.02 | 0.64 | 0.97 | 0.71 | 0.59 | 0.69 | 0.69 | 0.91 | 1.25 | 1.11 | 0.91 | 0.82 | 1.11 | 0.75 |
| Total Benefits & Expenses | 2.51 | 1.54 | 1.23 | 0.78 | 2.74 | 0.37 | 1.83 | 1.41 | 0.69 | 2.57 | 0.58 | 0.50 | 1.94 | 1.78 | 2.35 | 2.58 | 1.93 | 1.97 | 2.02 | 1.66 |
| Tax Provision | (0.22) | 0.01 | 0.10 | 0.01 | (0.09) | 0.16 | 0.01 | (0.02) | (0.12) | (0.26) | 0.11 | (0.06) | (0.16) | (0.38) | (0.19) | 0.23 | 0.17 | (0.01) | 0.11 | (0.01) |
| Net Income | (0.77) | 0.14 | 0.48 | 0.09 | (0.27) | 0.67 | 0.18 | 0.03 | (0.49) | (0.92) | 0.48 | (0.17) | (0.50) | (0.94) | (0.68) | 0.98 | 0.64 | 0.06 | 0.38 | 0.03 |
| Diluted EPS | (13.82) | 1.84 | 7.89 | 1.02 | (5.04) | 10.27 | 2.47 | 0.12 | (8.22) | (14.55) | 6.89 | (3.01) | (7.72) | (12.22) | (9.82) | 12.77 | 7.91 | 0.15 | 4.34 | 0.11 |
Cash Flow Statement
(in billions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | (0.22) | -0.00 | 0.12 | -0.00 | 0.15 | (0.12) | 0.02 | 0.33 | (0.53) | 0.15 | 0.34 | (0.13) | (0.50) | (0.21) | (0.96) | 0.18 | (0.16) | 0.10 | 0.57 | 0.17 |
| Investing Cash Flow | (0.48) | (1.30) | 1.37 | 0.11 | 0.56 | (0.36) | (0.13) | (1.08) | (0.62) | (0.55) | (0.98) | (0.33) | (1.32) | (0.68) | (2.58) | (2.50) | (2.52) | (2.57) | (5.25) | (4.21) |
| Financing Cash Flow | 0.23 | 0.08 | (0.42) | 0.76 | (1.09) | (0.11) | 1.30 | 1.37 | 1.13 | 0.41 | 0.75 | 0.51 | 1.40 | 0.21 | 3.26 | 3.29 | 2.31 | 2.84 | 3.90 | 4.90 |
